Guillain-Barré syndrome animal model: The first proof of molecular mimicry in human autoimmune disorder

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Yuki, Nobuhiro ^b   Shahrizaila, Nortina ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE BRAIN GANGLIOSIDE; COMPLEMENT INHIBITOR; GANGLIOSIDE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; GANGLIOSIDE GM1 ANTIBODY; GLYCOLIPID; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; LIPOOLIGOSACCHARIDE; NAFAMSTAT MESILATE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ACUTE GASTROENTERITIS; ACUTE MOTOR AXONAL NEUROPATHY; AUTOIMMUNE DISEASE; BACTERIUM ISOLATE; BLOOD SAMPLING; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CELL SURFACE; CLINICAL TRIAL (TOPIC); DEMYELINATION; DISEASE COURSE; DRUG INHIBITION; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNIZATION; IMMUNOTHERAPY; MOLECULAR MIMICRY; MOTOR NEUROPATHY; MUSCLE WEAKNESS; NEUROMUSCULAR DISEASE; NONHUMAN; OUTER MEMBRANE; PARALYSIS; PATHOGENESIS; PLASMAPHERESIS; RABBIT; REVIEW; RISK FACTOR; ANIMAL; DISEASE MODEL; PATHOLOGY;

ANIMALIA; CAMPYLOBACTER JEJUNI; NEGIBACTERIA; ORYCTOLAGUS CUNICULUS;

ANIMALS; DISEASE MODELS, ANIMAL; GUILLAIN-BARRE SYNDROME; HUMANS; MOLECULAR MIMICRY; RABBITS;

EID: 79251588034     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/829129     Document Type: Review

References (26)

1. Falkow S., Molecular Koch's postulates applied to microbial pathogenicity Reviews of Infectious Diseases 1988 10 supplement 2 S274 S276
2. Witebsky E., Rose N. R., Terplan K., Paine J. R., Egan R. W., Chronic thyroiditis and autoimmunization JAMA 1957 164 13 1439 1447
3. Ang C. W., Jacobs B. C., Laman J. D., The Guillain-Barr syndrome: a true case of molecular mimicry Trends in Immunology 2004 25 2 61 66
4. Rose N. R., Mackay I. R., Molecular mimicry: a critical look at exemplary instances in human diseases Cellular and Molecular Life Sciences 2000 57 4 542 551
5. van Doorn P. A., Ruts L., Jacobs B. C., Clinical features, pathogenesis, and treatment of Guillain-Barr syndrome The Lancet Neurology 2008 7 10 939 950
6. Asbury A. K., McKhann G. M., Changing views of Guillain-Barr syndrome Annals of Neurology 1997 41 3 287 288
7. Rees J. H., Soudain S. E., Gregson N. A., Hughes R. A. C., Campylobacter jejuni infection and Guillain-Barr syndrome The New England Journal of Medicine 1995 333 21 1374 1379
8. Kuwabara S., Ogawara K., Misawa S., Koga M., Mori M., Hiraga A., Kanesaka T., Hattori T., Yuki N., Does Campylobacter jejuni infection elicit demyelinating Guillain-Barr syndrome Neurology 2004 63 3 529 533
9. Hughes R. A. C., Swan A. V., Raphal J.-C., Annane D., van Koningsveld R., van Doorn P. A., Immunotherapy for Guillain-Barr syndrome: a systematic review Brain 2007 130 9 2245 2257
10. Hafer-Macko C., Hsieh S.-T., Yan Li C., Ho T. W., Sheikh K., Cornblath D. R., McKhann G. M., Asbury A. K., Griffin J. W., Acute motor axonal neuropathy: an antibody-mediated attack on axolemma Annals of Neurology 1996 40 4 635 644
11. Yuki N., Yoshino H., Sato S., Miyatake T., Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis Neurology 1990 40 12 1900 1902
12. Ho T. W., Willison H. J., Nachamkin I., Li C. Y., Veitch J., Ung H., Wang G. R., Liu R. C., Cornblath D. R., Asbury A. K., Griffin J. W., McKhann G. M., Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr syndrome Annals of Neurology 1999 45 2 168 173
13. Yuki N., Taki T., Inagaki F., Kasama T., Takahashi M., Saito K., Handa S., Miyatake T., A bacterium lipopolysaccharide that elicits Guillain-Barr syndrome has a GM1 ganglioside-like structure Journal of Experimental Medicine 1993 178 5 1771 1775
14. Koga M., Takahashi M., Masuda M., Hirata K., Yuki N., Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barr syndrome Neurology 2005 65 9 1376 1381
15. Illa I., Ortiz N., Gallard E., Juarez C., Grau J. M., Dalakas M. C., Acute axonal Guillain-Barr syndrome with IgG antibodies against motor axons following parenteral gangliosides Annals of Neurology 1995 38 2 218 224
16. Yuki N., Yamada M., Koga M., Odaka M., Susuki K., Tagawa Y., Ueda S., Kasama T., Ohnishi A., Hayashi S., Takahashi H., Kamijo M., Hirata K., Animal model of axonal Guillain-Barr syndrome induced by sensitization with GM1 ganglioside Annals of Neurology 2001 49 6 712 720
17. Susuki K., Rasband M. N., Tohyama K., Koibuchi K., Okamoto S., Funakoshi K., Hirata K., Baba H., Yuki N., Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers Journal of Neuroscience 2007 27 15 3956 3967
18. McKhann G. M., Cornblath D. R., Griffin J. W., Ho T. W., Li C. Y., Jiang Z., Wu H. S., Zhaori G., Liu Y., Jou L. P., Liu T. C., Gao C. Y., Mao J. Y., Blaser M. J., Mishu B., Asbury A. K., Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China Annals of Neurology 1993 33 4 333 342
19. Yuki N., Susuki K., Koga M., Nishimoto Y., Odaka M., Hirata K., Taguchi K., Miyatake T., Furukawa K., Kobata T., Yamada M., Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barr syndrome Proceedings of the National Academy of Sciences of the United States of America 2004 101 31 11404 11409
20. Goodfellow J. A., Bowes T., Sheikh K., Odaka M., Halstead S. K., Humphreys P. D., Wagner E. R., Yuki N., Furukawa K., Furukawa K., Plomp J. J., Willison H. J., Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy Journal of Neuroscience 2005 25 7 1620 1628
21. Griffin J. W., Li C. Y., Macko C., Ho T. W., Hsieh S.-T., Xue P., Wang F. A., Cornblath D. R., McKhann G. M., Asbury A. K., Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barr syndrome Journal of Neurocytology 1996 25 1 33 51
22. Kuwabara S., Ogawara K., Sung J.-Y., Mori M., Kanai K., Hattori T., Yuki N., Lin C. S.-Y., Burke D., Bostock H., Differences in membrane properties of axonal and demyelinating Guillain-Barr syndromes Annals of Neurology 2002 52 2 180 187
23. Hirota N., Kaji R., Bostock H., Shindo K., Kawasaki T., Mizutani K., Oka N., Kohara N., Saida T., Kimura J., The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons Brain 1997 120 12 2159 2169
24. Takigawa T., Yasuda H., Kikkawa R., Shigeta Y., Saida T., Kitasato H., Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers Annals of Neurology 1995 37 4 436 442
25. Hafer-Macko C. E., Sheikh K. A., Li C. Y., Ho T. W., Cornblath D. R., McKhann G. M., Asbury A. K., Griffin J. W., Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy Annals of Neurology 1996 39 5 625 635
26. Phongsisay V., Susuki K., Matsuno K., Yamahashi T., Okamoto S., Funakoshi K., Hirata K., Shinoda M., Yuki N., Complement inhibitor prevents disruption of sodium channel clusters in a rabbit model of Guillain-Barr syndrome Journal of Neuroimmunology 2008 205 1-2 101 104